Executive Director, Hematology Oncology Product Development

Regulatory Jobs; Rahway (NJ); Hybrid; USD 311,000 - 489,000; Full time

Job summary

Merck & Co., Inc. in Rahway, NJ is seeking an Executive Director (Distinguished Scientist) to steer the late-stage oncology clinical program, from Phase 2 to Phase 5, and to lead the product development team in strategy, execution, and external collaborations.

The role requires MD/PhD with extensive drug development experience, strong leadership, and ability to communicate complex scientific data to diverse audiences. Hybrid work arrangement and competitive compensation await.

Qualifications

• MD or MD/PhD required.
• Minimum of 3 years of clinical medicine experience.
• Minimum of 5 years of industry experience in drug development with success across multiple studies.
• Experience in authoring regulatory documents and engaging with agencies.
• Proven scientific scholarship and publication record.
• Strong leadership and collaboration in a matrix environment.

Responsibilities

• Plan and direct late-stage clinical development from Phase 2 to Phase 5.
• Lead cross-functional PDTs and provide scientific leadership.
• Develop clinical development strategies considering regulatory and commercial factors.
• Design and initiate clinical trials, monitor execution and analysis.
• Interact with external scientific leaders and regulators.
• Prepare documents for regulatory submissions and publications.
• Present governance updates to senior management and ensure alignment.

Skills

Clinical Development

Clinical Judgment

Clinical Medicine

Clinical Trial Development

Ethical Standards

Hematology

Intellectual Curiosity

Interdisciplinary Problem Solving

Lymphoma

Mentorship

Program Strategy

Regulatory Compliance

Scientific Leadership

Senior Program Management

Strategic Planning

Education

MD or MD./Ph.D.

Job description

Merck & Co., Inc. in Rahway, NJ is seeking an Executive Director (Distinguished Scientist) to steer the late-stage oncology clinical program, from Phase 2 to Phase 5, and to lead the product development team in strategy, execution, and external collaborations.

The role requires MD/PhD with extensive drug development experience, strong leadership, and ability to communicate complex scientific data to diverse audiences. Hybrid work arrangement and competitive compensation await.